Inactive Instrument

Highlights Samsara Vision, Inc.

Equities

Samsara Vision Announces First U.S. Surgeries of the Sing Imt, for Age-Related Macular Degeneration as Part of the Concerto Study	22-07-11	CI
Samsara Vision and Lansheng Medical “Myvision” Announce Collaboration to Commercialize the Sing Imt™ in China	22-06-08	CI
Samsara Vision, Inc. to Initiate A U.S. Pma Supplemental Study of the Sing Imt™, A New-Generation Technology for Age-Related Macular Degeneration	22-04-20	CI
Samsara Vision, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-11	CI
Samsara Vision, Inc. Announces the First Three Successful Clinical Cases in Italy Using Its Sing Imt™	22-02-22	CI
Samsara Vision, Inc. has filed an IPO.	21-11-03	CI
Visioncare Ophthalmic Technologies, Inc. Receives Health Canada Medical Device License for AMD Treatment	12-11-27	CI
VisionCare Ophthalmic Technologies, Inc. Receives Health Canada License for Telescope Prosthesis for End-Stage Macular Degeneration	12-11-08	CI
Florida Medicare Contractor Covers VisionCare Ophthalmic Technologies, Inc.'s Telescope Implant for End-Stage Macular Degeneration	12-10-09	CI
VisionCare Ophthalmic Technologies, Inc. Expands its CentraSight(TM) Provider Teams Nationwide	12-06-08	CI

No results for this search